LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.01
 17.28 27.76 62 838 0.0739 0.1775
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 17.28 27.76 1187 838 1.4153 1.1464
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 18.98 27.76 723 941 0.7682 0.8989
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 18.98 27.76 1047 941 1.1125 1.0424
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 18.98 27.76 68 941 0.0723 0.1927
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 18.98 27.76 1059 941 1.1252 1.0470
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 20.68 27.76 883 1119 0.7891 0.9131
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 20.68 27.76 1049 1119 0.9374 0.9759
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 20.68 27.76 72 1119 0.0643 0.1957
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 20.68 27.76 1168 1119 1.0438 1.0161
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 22.39 27.76 958 1305 0.7337 0.8916
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 22.39 27.76 1071 1305 0.8202 0.9299
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 22.39 27.76 87 1305 0.0666 0.2283
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 22.39 27.76 931 1305 0.7130 0.8819
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 24.09 27.76 980 1461 0.6705 0.8650
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 24.09 27.76 1064 1461 0.7280 0.8920
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 24.09 27.76 91 1461 0.0623 0.2308
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 24.09 27.76 859 1461 0.5877 0.8225
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 25.79 27.76 994 1605 0.6193 0.8428
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 25.79 27.76 1064 1605 0.6629 0.8643
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 25.79 27.76 105 1605 0.0654 0.2552
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 25.79 27.76 988 1605 0.6155 0.8409
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
 27.49 27.76 990 1723 0.5745 0.8223
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 27.49 27.76 1055 1723 0.6123 0.8419
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
 27.49 27.76 126 1723 0.0731 0.2892
MN20160318_Q01
M14